Drug intelligence / Profile preview

RV4620A + RP2552

Development stage
Preclinical
Modality
Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

RV4620A + RP2552 is a dermo-cosmetic broad-spectrum SPF50+ sunscreen formulation evaluated in observational clinical studies for in-use tolerance, cosmetic acceptability, and effects on skin barrier function in adults and children with mild atopic dermatitis.[4][2][6][5] The product is described as a very high protection sunscreen for face and body, intended for subjects with sensitive, reactive skin, including those exposed to irritative factors such as chlorine, sand, salt, and sweat.[4][2] Clinical assessments focus on dermatological and pediatric tolerance, user satisfaction, and instrumental measures of transepidermal water loss, skin pH, and sebum excretion to characterize its impact on the skin barrier, but specific active UV filter ingredients and mechanistic targets are not disclosed in the available trial records.[4][2]

Other names
Broadspectrum Sunscreen RV4620A RP2552Sunscreen RV4620A RP2552Solcreme RV4620A RP2552

Beyond the preview

Go deeper on RV4620A + RP2552.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RV4620A + RP2552.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call